GlassScriptPhysician profile
Whitnie S Padron
NPI 1003149519
$4,590.25
in general payments reported to CMS, 2019-2025
12 companies · $1,567 in 2025
The $1,567 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $765 · 2022: $12.82 · 2023: $475 · 2024: $1,770 · 2025: $1,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,812.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $4,161.81 | 2021-2025 | Xeomin |
| Janssen Biotech, INC. | $92.21 | 2021 | |
| Abbvie INC. | $89.03 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $55.57 | 2021 | |
| Novartis Pharmaceuticals Corporation | $47.10 | 2021 | |
| Lilly USA, LLC | $31.24 | 2021 | |
| Vyne Pharmaceuticals INC. | $25.00 | 2021 | |
| Almirall LLC | $22.04 | 2021 | |
| Phadia US INC. | $19.88 | 2025 | Immunocap |
| Sun Pharmaceutical Industries INC. | $17.02 | 2021 | |
| Pfizer INC. | $16.53 | 2021 | |
| Dexcom, INC. | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitnie Padron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.